Pediatric Study Planning With FDA, EMA To Be More Closely Aligned

Beginning in January, FDA will require initial pediatric study plans be submitted after the end-of-Phase II meeting, rather than well into Phase III, which is expected to improve planning and expand coordination with EMA.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from United States

More from North America